Tumour p53 mutations exhibit promoter selective dominance over wild type p53

Paola Monti, Paola Campomenosi, Yari Ciribilli, Raffaella Iannone, Alberto Inga, Angelo Abbondandolo, Michael A. Resnick, Gilberto Fronza

Research output: Contribution to journalArticle

Abstract

The tumour suppressor gene p53 is frequently mutated in human cancer. Tumour derived p53 mutants are usually transcriptionally inactive, but some mutants retain the ability to transactivate a subset of p53 target genes. In addition to simple loss of function, some p53 mutants may be carcinogenic through a dominant negative mechanism. Aiming at a more general classification of p53 mutants into predictive functional categories it is important to determine (i) which p53 mutants are dominant, (ii) what features characterize dominant mutants and (iii) whether dominance is target gene specific. The ability of 71 p53 mutants to inhibit wild type p53 was determined using a simple yeast transcriptional assay. Approximately 30% of the mutants were dominant. They preferentially affect highly conserved amino acids (P

Original languageEnglish
Pages (from-to)1641-1648
Number of pages8
JournalOncogene
Volume21
Issue number11
DOIs
Publication statusPublished - Mar 7 2002

Fingerprint

Mutation
p53 Genes
Tumor Suppressor Genes
Neoplasms
Yeasts
Amino Acids
Genes

Keywords

  • Dominance
  • Mutation
  • p53
  • p53 responsive element
  • Yeast functional assay

ASJC Scopus subject areas

  • Cancer Research
  • Genetics
  • Molecular Biology

Cite this

Monti, P., Campomenosi, P., Ciribilli, Y., Iannone, R., Inga, A., Abbondandolo, A., ... Fronza, G. (2002). Tumour p53 mutations exhibit promoter selective dominance over wild type p53. Oncogene, 21(11), 1641-1648. https://doi.org/10.1038/sj/onc/1205250

Tumour p53 mutations exhibit promoter selective dominance over wild type p53. / Monti, Paola; Campomenosi, Paola; Ciribilli, Yari; Iannone, Raffaella; Inga, Alberto; Abbondandolo, Angelo; Resnick, Michael A.; Fronza, Gilberto.

In: Oncogene, Vol. 21, No. 11, 07.03.2002, p. 1641-1648.

Research output: Contribution to journalArticle

Monti, P, Campomenosi, P, Ciribilli, Y, Iannone, R, Inga, A, Abbondandolo, A, Resnick, MA & Fronza, G 2002, 'Tumour p53 mutations exhibit promoter selective dominance over wild type p53', Oncogene, vol. 21, no. 11, pp. 1641-1648. https://doi.org/10.1038/sj/onc/1205250
Monti P, Campomenosi P, Ciribilli Y, Iannone R, Inga A, Abbondandolo A et al. Tumour p53 mutations exhibit promoter selective dominance over wild type p53. Oncogene. 2002 Mar 7;21(11):1641-1648. https://doi.org/10.1038/sj/onc/1205250
Monti, Paola ; Campomenosi, Paola ; Ciribilli, Yari ; Iannone, Raffaella ; Inga, Alberto ; Abbondandolo, Angelo ; Resnick, Michael A. ; Fronza, Gilberto. / Tumour p53 mutations exhibit promoter selective dominance over wild type p53. In: Oncogene. 2002 ; Vol. 21, No. 11. pp. 1641-1648.
@article{9b3c93bf7b5b4a0fb93ef1d5622eb9ab,
title = "Tumour p53 mutations exhibit promoter selective dominance over wild type p53",
abstract = "The tumour suppressor gene p53 is frequently mutated in human cancer. Tumour derived p53 mutants are usually transcriptionally inactive, but some mutants retain the ability to transactivate a subset of p53 target genes. In addition to simple loss of function, some p53 mutants may be carcinogenic through a dominant negative mechanism. Aiming at a more general classification of p53 mutants into predictive functional categories it is important to determine (i) which p53 mutants are dominant, (ii) what features characterize dominant mutants and (iii) whether dominance is target gene specific. The ability of 71 p53 mutants to inhibit wild type p53 was determined using a simple yeast transcriptional assay. Approximately 30{\%} of the mutants were dominant. They preferentially affect highly conserved amino acids (P",
keywords = "Dominance, Mutation, p53, p53 responsive element, Yeast functional assay",
author = "Paola Monti and Paola Campomenosi and Yari Ciribilli and Raffaella Iannone and Alberto Inga and Angelo Abbondandolo and Resnick, {Michael A.} and Gilberto Fronza",
year = "2002",
month = "3",
day = "7",
doi = "10.1038/sj/onc/1205250",
language = "English",
volume = "21",
pages = "1641--1648",
journal = "Oncogene",
issn = "0950-9232",
publisher = "Nature Publishing Group",
number = "11",

}

TY - JOUR

T1 - Tumour p53 mutations exhibit promoter selective dominance over wild type p53

AU - Monti, Paola

AU - Campomenosi, Paola

AU - Ciribilli, Yari

AU - Iannone, Raffaella

AU - Inga, Alberto

AU - Abbondandolo, Angelo

AU - Resnick, Michael A.

AU - Fronza, Gilberto

PY - 2002/3/7

Y1 - 2002/3/7

N2 - The tumour suppressor gene p53 is frequently mutated in human cancer. Tumour derived p53 mutants are usually transcriptionally inactive, but some mutants retain the ability to transactivate a subset of p53 target genes. In addition to simple loss of function, some p53 mutants may be carcinogenic through a dominant negative mechanism. Aiming at a more general classification of p53 mutants into predictive functional categories it is important to determine (i) which p53 mutants are dominant, (ii) what features characterize dominant mutants and (iii) whether dominance is target gene specific. The ability of 71 p53 mutants to inhibit wild type p53 was determined using a simple yeast transcriptional assay. Approximately 30% of the mutants were dominant. They preferentially affect highly conserved amino acids (P

AB - The tumour suppressor gene p53 is frequently mutated in human cancer. Tumour derived p53 mutants are usually transcriptionally inactive, but some mutants retain the ability to transactivate a subset of p53 target genes. In addition to simple loss of function, some p53 mutants may be carcinogenic through a dominant negative mechanism. Aiming at a more general classification of p53 mutants into predictive functional categories it is important to determine (i) which p53 mutants are dominant, (ii) what features characterize dominant mutants and (iii) whether dominance is target gene specific. The ability of 71 p53 mutants to inhibit wild type p53 was determined using a simple yeast transcriptional assay. Approximately 30% of the mutants were dominant. They preferentially affect highly conserved amino acids (P

KW - Dominance

KW - Mutation

KW - p53

KW - p53 responsive element

KW - Yeast functional assay

UR - http://www.scopus.com/inward/record.url?scp=0037034946&partnerID=8YFLogxK

UR - http://www.scopus.com/inward/citedby.url?scp=0037034946&partnerID=8YFLogxK

U2 - 10.1038/sj/onc/1205250

DO - 10.1038/sj/onc/1205250

M3 - Article

VL - 21

SP - 1641

EP - 1648

JO - Oncogene

JF - Oncogene

SN - 0950-9232

IS - 11

ER -